QUALITY ASSURANCE INCLUDES monitoring the ALLOGRAFT TISSUE from donor screening (the mother) ALL the WAY THROUGH STORAGE AND DISTRIBUTION. ReBellaUC™ is processed from DONATED UMBILICAL cords from FULL term deliveries THAT HAVE UNDERGONE A SCHEDULED c-section.

All donors ARE pre-screened THROUGH the LAB’s MEDICAL Director AND UNDERGO comprehensive testing THAT INCLUDES:
• BEHAVIORAL risk ASSESSMENT
• PHYSICAL ASSESSMENT
• Donor MEDICAL history
• COMMUNICABLE DISEASE testing
INFECTIOUS DISEASE testing is performed AT A third PARTY, certified LABORATORY in ACCORDANCE with the CLINICAL LABORATORY Improvement Amendments of 1988 (CLIA) AND 42 CFR

The PRODUCT is AVAILABLE with EXPANDED MSC COUNTS of either 5, 10, 20 or 50 million UNDER AN APPROVED IND.

Key FEATURES of REBELLAUCTM: Approved IND.
CONTAINS MARKERS of MSC’s: CD90, CD73, CD105.
95%+ VIABILITY.
Over 300 ongoing CLINICAL TRIALS.
Over 1000 PUBLICATIONS on ANTI-INFLAMMATORY CAPACITY.